MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 30525 |
Device Problems
Calcified (1077); Perivalvular Leak (1457); Structural Problem (2506)
|
Patient Problems
Death (1802); Hemorrhage, Cerebral (1889); Thromboembolism (2654)
|
Event Date 02/01/2016 |
Event Type
Death
|
Manufacturer Narrative
|
Title: the mosaic mitral valve bioprosthesis: a long-term clinical and hemodynamic follow-up citation: heart inst j 2016;43(1):13-9) authors: michele celiento, md, stefania blasi, md, andrea de martino, md, stefano pratali, md, aldo d.Milano, md, phd, uberto bortolotti, md.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether this event has been previously reported.(b)(4).
|
|
Event Description
|
Medtronic received information via literature review of a retrospective study performed to evaluate patients who underwent isolated mitral valve replacements from (b)(6) 1995 through (b)(6) 2011.The study population included 100 patients (predominantly male; mean age 73 ± years), all of which were implanted with a medtronic mosaic bioprosthetic valve (serial numbers not provided).Among all patients, 41 deaths occurred, 10 in-hospital deaths and 31 late deaths.Causes of death included: 8 cardiac, 2 cerebral embolism, 2 reoperation, and 1 unexpected.Of these deaths, five were deemed valve-related.Additionally, the following adverse events occurred: 4 thromboembolism, 1 cerebral hemorrhage, 3 cerebral embolic episodes, and 2 structural valve dysfunction (svd).Four patients required re-operation due to 2 svd (regurgitation, valve dehiscence, calcification and cuspal tear), 1 paravalvular leak (pvl), and 1 valve thrombosis.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Corrected information: sex.
|
|
Search Alerts/Recalls
|
|
|